|
2025
|
Invention
|
Ultrasound-mediated gene and drug delivery.
Transcutaneous, ultrasound-mediated methods for admi... |
|
|
Invention
|
Systems and methods for the analogical modeling of psychological structure. Systems and methods t... |
|
|
Invention
|
Systems and methods for processing respiratory data. An example computer system analyzes nasal ai... |
|
|
Invention
|
Modified vectors for xla gene therapy. This disclosure relates generally to vectors, typically vi... |
|
|
Invention
|
Cxcr3 isoforms to improve recombinant receptor trafficking. Artificial expression constructs enco... |
|
|
Invention
|
Inducible transcription factor expression for modulating immune cell function. Artificial express... |
|
|
Invention
|
Methods for treating severe tuberculosis. Methods for treating tuberculosis are provided. |
|
|
Invention
|
Gooseneck fracture reduction tool. A fracture reduction tool for performing bone fracture reducti... |
|
|
Invention
|
Candida auris detection. Candida aurisCandida aurisCandida aurisC. aurisC. aurisCandidaC. aurisC.... |
|
2024
|
Invention
|
Artificial expression constructs for selectively modulating gene expression in interneurons.
Art... |
|
|
Invention
|
Newborn screening for primary immunodeficiencies, cystinosis, and wilson disease.
Newborn screen... |
|
|
Invention
|
Sequencing method for car t cell therapy.
The present disclosure relates to methods of treating ... |
|
|
Invention
|
Protective monoclonal antibodies to pseudomonas aeruginosa. aeruginosa aeruginosaP.aeruginosaaeru... |
|
|
Invention
|
Inducible cellular suicide switches. Some embodiments of the methods and compositions provided he... |
|
|
Invention
|
Rescuing voltage-gated sodium channel function in inhibitory neurons.
Selectively providing volt... |
|
|
Invention
|
Systems and methods for polymer-mediated activation of engineered cells. Disclosed are systems fo... |
|
|
Invention
|
Nucleic acids encoding il-13 receptor alpha 2 (il13ra2) chimeric antigen receptor for tumor speci... |
|
|
Invention
|
Inducible transgenes encoding intracellular molecules for modulating immune cell function. Artifi... |
|
|
Invention
|
Methods and compositions comprising antigen specific b cells. Some embodiments provided herein re... |
|
|
Invention
|
Immune cell engaging molecules. Multi-specific immune cell engaging molecules are provided herein... |
|
|
Invention
|
Systems and methods for improving safety of split intein aav mediated gene therapy. Systems and m... |
|
|
Invention
|
Bispecific chimeric antigen receptors and therapeutic uses thereof.
The invention is directed to... |
|
|
Invention
|
A4b1 binding aptamers.
Various implementations described herein relate to oligonucleotides that ... |
|
|
Invention
|
Modified vectors. This disclosure relates generally to viral vectors useful for gene therapy appl... |
|
|
Invention
|
A multi-stage vaccine antigen for malaria. The present disclosure provides a recombinant antigen ... |
|
|
Invention
|
Asymmetric circular tandem repeat proteins. In certain embodiments, the present invention provide... |
|
|
Invention
|
Systems and methods to provide therapeutic factor viii using ultrasound-mediated nucleic acid del... |
|
|
Invention
|
Mutant interleukin 15 expressing immune cells. The present disclosure provides methods and artifi... |
|
|
Invention
|
Inducible programmed cell death-1 (pd1)-cytokine chimera for potentiated immune cell function. Ar... |
|
|
Invention
|
Therapeutic methods. The invention provides methods for treating a disease associated with SRC Fa... |
|
|
Invention
|
Proteomic screening for lysosomal storage diseases.
Early detection of lysosomal storage disease... |
|
|
Invention
|
Intein-mediated reconstitution of voltage-gated sodium channel function. Artificial expression co... |
|
|
Invention
|
Inducible cytokine transgenes for potentiated immune cell function. Artificial expression constru... |
|
|
Invention
|
Cd62l (l-selectin) aptamer and its application for t cell isolation. Various implementations desc... |
|
2023
|
Invention
|
N-myristoyltransferase inhibitors and methods of use. Provided herein are compounds of Formula (I... |
|
|
Invention
|
Cerebral near infrared spectroscopy probe in infants and preterm neonates. An example method incl... |
|
|
Invention
|
Recombinant receptors binding b cell activation factor receptor and uses thereof.
Recombinant re... |
|
|
Invention
|
Inhibiting mast cell activation by binding sialic acid-binding immunoglobulin-like lectin-9 (sigl... |
|
|
Invention
|
Ventilation system.
A system includes a container configured to contain a liquid. The system als... |
|
|
Invention
|
Recombinant proteins that stimulate an immune response in the presence of naturally inhibitory li... |
|
|
Invention
|
Simplified method of preparing cells for patient administration.
The current disclosure describe... |
|
2022
|
Invention
|
Methods and systems to functionally ablate 3 prime rna ends.
Methods and systems to functionally... |
|
|
Invention
|
Compositions incorporating a genetically attenuated plasmodium with modified liver stage nuclear ... |
|
|
Invention
|
T-cell manufacturing methods.
T cell manufacturing methods that co-culture T cells with autologo... |
|
|
Invention
|
Synthetic nucleic acid elements for enhancing car t cell efficacy.
Some embodiments of the metho... |
|
|
Invention
|
Activity-inducible fusion proteins having a transcription factor and a heat shock protein 90 bind... |
|
|
Invention
|
Gene editing for expression of functional factor viii for the treatment of hemophilia.
Gene-edit... |
|
|
Invention
|
Engineering peptides for a a vb6 integrin binding and related methods of use and synthesis.
Embo... |
|
|
Invention
|
Systems and methods for clearing indwelling catheters.
Systems, devices, and methods for clearin... |
|
|
Invention
|
Activity-inducible fusion proteins having a heat shock protein 90 binding domain.
Activity-induc... |
